p53 recruitment of CREB binding protein mediated through phosphorylated CREB: a novel pathway of tumor suppressor regulation

Citation
Ha. Giebler et al., p53 recruitment of CREB binding protein mediated through phosphorylated CREB: a novel pathway of tumor suppressor regulation, MOL CELL B, 20(13), 2000, pp. 4849-4858
Citations number
38
Categorie Soggetti
Molecular Biology & Genetics
Journal title
MOLECULAR AND CELLULAR BIOLOGY
ISSN journal
02707306 → ACNP
Volume
20
Issue
13
Year of publication
2000
Pages
4849 - 4858
Database
ISI
SICI code
0270-7306(200007)20:13<4849:PROCBP>2.0.ZU;2-L
Abstract
CREB binding protein (CBP) is a 270-kDa nuclear protein required for activa ted transcription of a large number of cellular genes. Although CBP was ori ginally discovered through its interaction with phosphorylated CREB (pCREB) , it is utilized by a multitude of cellular transcription factors and viral oncoproteins. Both CREB and the tumor suppressor p53 have been shown to di rectly interact with the KIX domain of CBP. Although coactivator competitio n is an emerging theme in transcriptional regulation, we have made the fort uitous observation that protein kinase A-phosphorylated CREB strongly enhan ces p53 association with KIX. Phosphorylated CREB also facilitates interact ion of a p53 mutant, defective for KIX binding, indicating that CREB functi ons in a novel way to bridge p53 and the coactivator. This is accomplished through direct interaction between the bZIP domain of CREB and the amino te rminus of p53; a protein-protein interaction that is also detected in vivo. Consistent with our biochemical observations, we show that stimulation of the intracellular cyclic AMP (cAMP) pathway, which leads to CREB phosphoryl ation, strongly enhances both the transcriptional activation and apoptotic properties of p53. We propose that phosphorylated CREB mediates recruitment of CBP to p53-responsive promoters through direct interaction with p53. Th ese observations provide evidence for a novel pathway that integrates cAMP signaling and p53 transcriptional activity.